The PRISMAP network was recently launched which will see more than 20 European academic institutions and research centers pooling their knowledge, expertise and infrastructure to speed up the introduction of new medical radioisotopes. The network aims to provide a sustainable source of high-purity grade novel radionuclides for medical research.

PRISMAP federates a European consortium of the key intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical and healthcare research institutes in the active translation of the emerging radionuclides into medical diagnosis and treatment. PRISMAP said it creates a single entry point for a "fragmented user community" distributed amongst universities, research centers, industry and hospitals, in a similar way to how the National Isotope Development Center, supported by the US Department of Energy, has provided radionuclide sources for users in the USA.

The PRISMAP consortium comprises 23 partners including nine major EU, national or regional ones and four emerging "infrastructures", as well as top-level research centers, hospitals, the European Joint Research Centre and one SME. The PRISMAP partners come from 13 different countries: Austria, Belgium, Denmark, France, Germany, Italy, Latvia, Norway, Poland, Portugal, Sweden, Switzerland and the UK, under the coordination of CERN, the European Laboratory for Nuclear Research.

To read more please visit:

European Medical Isotope Network Launched

Source: wnn